Andere talen Krebs Biochemicals & Industries Limited NSE India S.E.

Aandelen

KREBSBIO

INE268B01013

Beurs gesloten - NSE India S.E. Andere beurzen 13:43:55 28-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
70,95 ^INR	-0,49%		-0,52%	-9,44%

21/05	Krebs Biochemicals & Industries Limited benoemt Rakesh Kalbate tot bedrijfssecretaris/compliance officer	CI
21/05	Krebs Biochemicals & Industries Limited rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer	21/05
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	21/05
Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer	15/04
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer	17/01
Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant	18/12
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer	20-10-23
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	09-08-23
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director	09-08-23
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023	09-08-23
Krebs Biochemicals Trims Net Loss in Fiscal Q4	24-05-23
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	24-05-23
Krebs Biochemicals Names New CFO	03-02-23
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer	03-02-23
Krebs Biochemicals & Industries Limited Approves CFO Changes	03-02-23
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10-11-22
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt	06-09-22
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	01-08-22
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022	01-08-22
Krebs Biochemicals & Industries : Financial Result Updates	23-05-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Krebs Biochemicals & Industries Limited NSE India S.E.

Aandelen

KREBSBIO

INE268B01013

Andere talen

Filters